Glatiramer is indicated for the treatment of relapsing forms of multiple sclerosis (MS).
For this indication, competent medicine agencies globally authorize below treatments:
20 - 20 mg
From 20 To 20 mg once every day
The recommended dosage in adults is 20 mg of glatiramer acetate, administered as a subcutaneous injection once daily.
At the present time, it is not known for how long the patient should be treated.
A decision concerning long term treatment should be made on an individual basis by the treating physician.
A different site should be chosen for every injection, so this will reduce the chances of any irritation or pain at the site of the injection. Sites for self-injection include the abdomen, arms, hips and thighs.